Antihypertensives in dementia: Good or bad for the brain?

We discuss the current evidence for both benefit and harm of antihypertensive treatment in people with dementia. We conclude that there is a lack of evidence to support the claim that there is an increased risk of cerebral hypoperfusion with antihypertensive treatment in dementia, and that there is...

Descripción completa

Detalles Bibliográficos
Autores principales: Heutz, Rachel AM, Weijs, Ralf WJ, de Heus, Rianne AA, Claassen, Jurgen AHR
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Commentaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581244/
https://www.ncbi.nlm.nih.gov/pubmed/37243524
http://dx.doi.org/10.1177/0271678X231179421
_version_ 1785122099505922048
author Heutz, Rachel AM
Weijs, Ralf WJ
de Heus, Rianne AA
Claassen, Jurgen AHR
author_facet Heutz, Rachel AM
Weijs, Ralf WJ
de Heus, Rianne AA
Claassen, Jurgen AHR
author_sort Heutz, Rachel AM
collection PubMed
description We discuss the current evidence for both benefit and harm of antihypertensive treatment in people with dementia. We conclude that there is a lack of evidence to support the claim that there is an increased risk of cerebral hypoperfusion with antihypertensive treatment in dementia, and that there is growing evidence which refutes this claim.
format Online
Article
Text
id pubmed-10581244
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-105812442023-10-18 Antihypertensives in dementia: Good or bad for the brain? Heutz, Rachel AM Weijs, Ralf WJ de Heus, Rianne AA Claassen, Jurgen AHR J Cereb Blood Flow Metab Commentaries We discuss the current evidence for both benefit and harm of antihypertensive treatment in people with dementia. We conclude that there is a lack of evidence to support the claim that there is an increased risk of cerebral hypoperfusion with antihypertensive treatment in dementia, and that there is growing evidence which refutes this claim. SAGE Publications 2023-05-27 2023-10 /pmc/articles/PMC10581244/ /pubmed/37243524 http://dx.doi.org/10.1177/0271678X231179421 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Commentaries
Heutz, Rachel AM
Weijs, Ralf WJ
de Heus, Rianne AA
Claassen, Jurgen AHR
Antihypertensives in dementia: Good or bad for the brain?
title Antihypertensives in dementia: Good or bad for the brain?
title_full Antihypertensives in dementia: Good or bad for the brain?
title_fullStr Antihypertensives in dementia: Good or bad for the brain?
title_full_unstemmed Antihypertensives in dementia: Good or bad for the brain?
title_short Antihypertensives in dementia: Good or bad for the brain?
title_sort antihypertensives in dementia: good or bad for the brain?
topic Commentaries
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581244/
https://www.ncbi.nlm.nih.gov/pubmed/37243524
http://dx.doi.org/10.1177/0271678X231179421
work_keys_str_mv AT heutzrachelam antihypertensivesindementiagoodorbadforthebrain
AT weijsralfwj antihypertensivesindementiagoodorbadforthebrain
AT deheusrianneaa antihypertensivesindementiagoodorbadforthebrain
AT claassenjurgenahr antihypertensivesindementiagoodorbadforthebrain

Ejemplares similares